AKT1 and thyroid cancer: Loss of expression of the oncosuppressor PTEN, a protein–lipid phosphatase that switches off the AKT pathway, was associated with the surface expression of GLUT1 and increased the possibility of “incidental” detection of thyroid cancer based on FDG–PET [33].